Rate of Contrast Extravasation on Computed Tomographic Angiography Predicts Hematoma Expansion and Mortality in Primary Intracerebral Hemorrhage

Background and Purpose— In primary intracerebral hemorrhage, the presence of contrast extravasation after computed tomographic angiography (CTA), termed the spot sign, predicts hematoma expansion and mortality. Because the biological underpinnings of the spot sign are not fully understood, we investigated whether the rate of contrast extravasation, which may reflect the rate of bleeding, predicts expansion and mortality beyond the simple presence of the spot sign. Methods— Consecutive intracerebral hemorrhage patients with first-pass CTA followed by a 90-second delayed postcontrast CT (delayed CTA) were included. CTAs were reviewed for spot sign presence by 2 blinded readers. Spot sign volumes on first-pass and delayed CTA and intracerebral hemorrhage volumes were measured using semiautomated software. Extravasation rates were calculated and tested for association with hematoma expansion and mortality using uni- and multivariable logistic regressions. Results— One hundred and sixty-two patients were included, 48 (30%) of whom had ≥1 spot sign. Median spot sign volume was 0.04 mL on first-pass CTA and 0.4 mL on delayed CTA. Median extravasation rate was 0.23 mL/min overall and 0.30 mL/min among expanders versus 0.07 mL/min in nonexpanders. Extravasation rates were also significantly higher in patients who died in hospital: 0.27 mL/min versus 0.04 mL/min. In multivariable analysis, the extravasation rate was independently associated with in-hospital mortality (odds ratio, 1.09 [95% confidence interval, 1.04–1.18], P=0.004), 90-day mortality (odds ratio, 1.15 [95% confidence interval, 1.08–1.27]; P=0.0004), and hematoma expansion (odds ratio, 1.03 [95% confidence interval, 1.01–1.08]; P=0.047). Conclusions— Contrast extravasation rate, or spot sign growth, further refines the ability to predict hematoma expansion and mortality. Our results support the hypothesis that the spot sign directly measures active bleeding in acute intracerebral hemorrhage.

[1]  R. Gonzalez,et al.  Prospective Validation of the Computed Tomographic Angiography Spot Sign Score for Intracerebral Hemorrhage , 2013, Stroke.

[2]  M. Woodward,et al.  Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.

[3]  S. Greenberg,et al.  Hematoma Expansion following Acute Intracerebral Hemorrhage , 2013, Cerebrovascular Diseases.

[4]  Mukul Sharma,et al.  Ongoing bleeding in acute intracerebral haemorrhage , 2013, The Lancet.

[5]  R. Aviv,et al.  Histopathological characteristics of the "spot sign" in spontaneous intracerebral hemorrhage. , 2012, Archives of neurology.

[6]  J. Goldstein,et al.  Clinical applications of the computed tomography angiography spot sign in acute intracerebral hemorrhage: a review. , 2012, Stroke.

[7]  Mark W Parsons,et al.  Hematoma growth and outcomes in intracerebral hemorrhage , 2012, Neurology.

[8]  A. Demchuk,et al.  Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study , 2012, The Lancet Neurology.

[9]  Y. Palesch,et al.  Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: Design, Methods, and Rationale , 2011, Neurocritical care.

[10]  Eric E. Smith,et al.  Defining hematoma expansion in intracerebral hemorrhage , 2011, Neurology.

[11]  W. Huebner,et al.  Strategies for using the National Death Index and the Social Security Administration for death ascertainment in large occupational cohort mortality studies. , 2010, American journal of epidemiology.

[12]  Gregory W Albers,et al.  Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials , 2010, The Lancet.

[13]  Ale Algra,et al.  Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis , 2010, The Lancet Neurology.

[14]  P. Schaefer,et al.  Systematic Characterization of the Computed Tomography Angiography Spot Sign in Primary Intracerebral Hemorrhage Identifies Patients at Highest Risk for Hematoma Expansion: The Spot Sign Score , 2009, Stroke.

[15]  S. Mayer,et al.  Can a Subset of Intracerebral Hemorrhage Patients Benefit From Hemostatic Therapy With Recombinant Activated Factor VII? , 2009, Stroke.

[16]  S. Mayer,et al.  Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. , 2008, The New England journal of medicine.

[17]  D. Gladstone,et al.  CT Angiography “Spot Sign” Predicts Hematoma Expansion in Acute Intracerebral Hemorrhage , 2007, Stroke.

[18]  Eric E. Smith,et al.  Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage , 2007, Neurology.

[19]  S. Mayer,et al.  Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage , 2007, Stroke.

[20]  S. Mayer,et al.  Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage , 2006, Neurology.

[21]  J. Broderick,et al.  Volume of Intracerebral Hemorrhage: A Powerful and Easy‐to‐Use Predictor of 30‐Day Mortality , 1993, Stroke.

[22]  C. Fisher,et al.  PATHOLOGICAL OBSERVATIONS IN HYPERTENSIVE CEREBRAL HEMORRHAGE , 1971, Journal of neuropathology and experimental neurology.

[23]  Fisher Cm.  Pathological observations in hypertensive cerebral hemorrhage. , 1971 .

[24]  G. Chang.  Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. , 2007, Neurology.

[25]  J. Broderick,et al.  Early hemorrhage growth in patients with intracerebral hemorrhage. , 1997, Stroke.

[26]  R. Betts.  American Heart Association. , 1958, Hospital management.